GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grapefruit USA Inc (OTCPK:GPFT) » Definitions » Debt-to-Equity

Grapefruit USA (Grapefruit USA) Debt-to-Equity : -0.72 (As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Grapefruit USA Debt-to-Equity?

Grapefruit USA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $4.95 Mil. Grapefruit USA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.00 Mil. Grapefruit USA's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $-6.93 Mil. Grapefruit USA's debt to equity for the quarter that ended in Sep. 2023 was -0.72.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Grapefruit USA's Debt-to-Equity or its related term are showing as below:

GPFT' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.34   Med: -0.28   Max: 1.7
Current: -0.72

During the past 13 years, the highest Debt-to-Equity Ratio of Grapefruit USA was 1.70. The lowest was -1.34. And the median was -0.28.

GPFT's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.3 vs GPFT: -0.72

Grapefruit USA Debt-to-Equity Historical Data

The historical data trend for Grapefruit USA's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grapefruit USA Debt-to-Equity Chart

Grapefruit USA Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.28 -0.41 -0.71 -1.08 -0.97

Grapefruit USA Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Sep23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.97 -0.97 -0.90 -0.91 -0.72

Competitive Comparison of Grapefruit USA's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Grapefruit USA's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grapefruit USA's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grapefruit USA's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Grapefruit USA's Debt-to-Equity falls into.



Grapefruit USA Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Grapefruit USA's Debt to Equity Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Grapefruit USA's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grapefruit USA  (OTCPK:GPFT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Grapefruit USA Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Grapefruit USA's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Grapefruit USA (Grapefruit USA) Business Description

Traded in Other Exchanges
N/A
Address
10866 Wilshire Boulevard, Suite 225, Los Angeles, CA, USA, 90024
Grapefruit USA Inc manufactures and distributes cannabis-based products. Its extraction lab produces high-quality distillate or Honey Oil from trim that Grapefruit sources through its Distribution arm. The company is a premier licensed Distributor of all things cannabis throughout the State of California. It serves licensed Medicinal and Recreational Dispensaries. Its patented product is Hourglass Cream. Grapefruit owns and operates a California-licensed cannabis extraction laboratory and wholesale distribution facility in the Coachillin' Canna-Business Park near Palm Springs, California.
Executives
Bradley J Yourist director, 10 percent owner, officer: Chairman and CEO 10866 WILSHIRE BLVD, #225, LOS ANGELES CA 90024
Daniel J. Yourist director, 10 percent owner, officer: Board of Directors and COO 10866 WILSHIRE BLVD, SUITE 225, LOS ANGELES CA 90024
Dane Medley director, officer: CEO/Chairman 10553 CAMARILLO STREET, TOLUCA LAKE CA 91602
Emilio Xavier Aguilera director, officer: Chief Financial Officer 16827 HALSEY STREET, GRANADA HILLS CA 91344
Dean Janes officer: CHIEF EXECUTIVE OFFICER 3200 W. VALHALLA DRIVE, BURBANK CA 91505
Christopher Sohn director, officer: President and COO 3200 W. VALHALLA DRIVE, BURBANK CA 91505
Xavier Aguilera director, officer: CFO/Treasurer,Exec.V.P.& Secy 3200 W. VALHALLA DRIVE, BURBANK CA 91505
Michele Janes officer: Vice President of Admin. 3200 W. VALHALLA DRIVE, BURBANK CA 91505